Apogee Therapeutics (APGE) Treasury Shares (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Treasury Shares data on file, last reported at $441330.0 in Q1 2026.

• On a quarterly basis, Treasury Shares fell 63.87% year-over-year to $441330.0 in Q1 2026; TTM through Mar 2026 was $441330.0, a 63.87% decrease from a year earlier, with the FY2025 full-year figure at $637594.0, down 54.97% from the prior year.
• Treasury Shares for Q1 2026 stood at $441330.0, down from $637594.0 in the prior quarter.
• Over the last five years, Treasury Shares for APGE reached as high as $65.1 million in Q4 2022 and fell as low as $144090.0 in Q4 2023.
• Historically, Treasury Shares has averaged $17.9 million across 5 years, with a median of $1.4 million in 2024.
• Across the five-year window, Treasury Shares sank 99.78% in 2023 and surged 138.3% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $65.1 million in 2022, then sank by 99.78% to $144090.0 in 2023, then soared by 85.69% to $267564.0 in 2024, then jumped by 138.3% to $637594.0 in 2025, then tumbled by 30.78% to $441330.0 in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $441330.0 in Q1 2026, $637594.0 in Q4 2025, and $831989.0 in Q3 2025.